HI
AQST icon

Harbour Investments’s Aquestive Therapeutics AQST Stock Holding History

Harbour Investments’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.4K Sell
576
-4,520
-89% -$19K ﹤0.01% 3955
2026
Q1 		$21.1K Buy
+5,096
New +$20.7K ﹤0.01% 2855
2021
Q4 		– Sell
-225
Closed -$1K – 2660
2021
Q3 		$1K Buy
225
+150
+200% +$588 ﹤0.01% 3429
2021
Q2 		$0 Hold
75
– – ﹤0.01% 3750
2021
Q1 		$0 Buy
+75
New +$399 ﹤0.01% 3584

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.8M AUM 25.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Harbour Investments's AQST Position: Q2 2026 in Review

Harbour Investments reduced its Aquestive Therapeutics (AQST) stake by 89% in Q2 2026, selling an estimated $19K and leaving 576 shares worth $2.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3955.

Harbour Investments first reported a position in AQST in Q1 2021 and has held it in 5 quarters since. The position peaked at $21.1K in Q1 2026. 184 funds tracked by Wall St. Rank hold AQST as of Q2 2026.

  • Harbour Investments held 576 shares of Aquestive Therapeutics worth $2.4K as of Q2 2026.
  • Harbour Investments sold 4,520 Aquestive Therapeutics shares in Q2 2026, an estimated $19K.
  • Aquestive Therapeutics made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #3955 holding.
  • Harbour Investments first reported a position in Aquestive Therapeutics in Q1 2021 and has held it in 5 quarters since.
  • Harbour Investments's Aquestive Therapeutics position peaked at $21.1K in Q1 2026.
  • 184 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.